Growth Metrics

Emergent BioSolutions (EBS) Goodwill (2016 - 2023)

Emergent BioSolutions has reported Goodwill over the past 14 years, most recently at $218.2 million for Q2 2023.

  • For Q2 2023, Goodwill fell 2.98% year-over-year to $218.2 million; the TTM value through Jun 2023 reached $218.2 million, down 2.98%, while the annual FY2022 figure was $218.2 million, 2.98% down from the prior year.
  • Goodwill for Q2 2023 was $218.2 million at Emergent BioSolutions, roughly flat from $218.2 million in the prior quarter.
  • Over five years, Goodwill peaked at $268.6 million in Q3 2019 and troughed at $218.2 million in Q4 2022.
  • A 5-year average of $249.5 million and a median of $266.4 million in 2020 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: skyrocketed 446.71% in 2019 and later dropped 15.67% in 2021.
  • Year by year, Goodwill stood at $266.6 million in 2019, then rose by 0.04% to $266.7 million in 2020, then dropped by 15.67% to $224.9 million in 2021, then fell by 2.98% to $218.2 million in 2022, then changed by 0.0% to $218.2 million in 2023.
  • Business Quant data shows Goodwill for EBS at $218.2 million in Q2 2023, $218.2 million in Q1 2023, and $218.2 million in Q4 2022.